欧洲急性老年病房的照护目标讨论与治疗限制决策:一日横断面研究
该研究调查了23个欧洲急性老年病房中590例75岁及以上住院患者的预立医疗指示、照护目标讨论及治疗限制决策情况。结果显示预立医疗指示记录率仅3.3%,入院前治疗限制为14.0%,照护目标讨论与治疗限制决策在欧洲地区间差异显著。结论认为各中心实践差异大,且基层与医院间患者意愿信息共享明显不足。
要点
- 预立医疗指示记录率仅3.3%,入院前治疗限制记录率为14.0%。
- 照护目标讨论与患者为64.0%、与家属为73.0%、与院内团队为67.0%、与基层为13.4%。
- 治疗限制决策 prevalence 为53.7%,国家内及国家间差异大。
核心结论
- 欧洲急性老年病房之间在照护目标讨论和治疗限制决策方面存在很大差异。
- 基层与医院之间关于患者偏好的信息共享明显不足。
研究设计与样本
- 研究为一日横断面研究,纳入23个欧洲急性老年病房中75岁及以上住院患者共590例。
- 收集了预立医疗指示、照护目标讨论及治疗限制决策的数据。
主要发现
- 590例患者中59.5%年龄85岁及以上,59.3%为女性,病前临床衰弱评分(CFS)中位数为6。
- 正式预立医疗指示记录率为3.3%,入院前治疗限制记录率为14.0%,两者在欧洲地区间差异显著(分别P < 0.001和P = 0.018)。
- 最常见照护目标为维持功能(46.8%)。
- 照护目标与患者讨论者为64.0%,与家属为73.0%,在院内多专业团队中讨论者为67.0%,与基层医疗讨论者为13.4%。
- 治疗限制决策的 prevalence 为53.7%,国家内和国家间差异大(P < 0.001)。
关键数值与推荐
- 有治疗限制决策的 odds 更高的因素包括:入院前已有治疗限制决策(OR 39.1)、居住在西欧 versus 南欧(OR 4.8)、年龄类别更高(OR 3.2)、严重共病数量更多(OR 2.2)、病前CFS更高(OR 1.3)。
临床怎么用
- 老年医学科应系统记录并尊重患者预立医疗指示与照护目标。
- 需加强基层与医院之间关于患者偏好和治疗限制决策的信息共享。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: It is important to pursue goal-concordant care and to prevent non-beneficial interventions in older people. AIM: To describe serious illness communication and decision-making practices in hospitalised older people in Europe. SETTING/PARTICIPANTS: Data on advance directives, goals of care (GOC) discussions and treatment limitation decisions were collected about patients aged 75-years and older admitted to 23 European acute geriatric units (AGUs). RESULTS: In this cohort of 590 older persons [59.5% aged 85 and above, 59.3% female, median premorbid Clinical Frailty Score (CFS) 6], a formal advance directive was recorded in 3.3% and a pre-hospital treatment limitation in 14.0% with significant differences between European regions (respectively P < 0.001 and P = 0.018).Most prevalent GOC was preservation of function (46.8%). GOC were discussed with patients in 64.0%, with families in 73.0%, within the interprofessional hospital team in 67.0% and with primary care in 13.4%. The GOC and the extent to which it was discussed differed between European regions (both P < 0.001). The prevalence of treatment limitation decisions was 53.7% with a large difference within and between countries (P < 0.001). The odds of having a treatment limitation decision were higher for patients with pre-hospital treatment limitation decisions (OR 39.1), residing in Western versus Southern Europe (OR 4.8), belonging to an older age category (OR 3.2), living with a higher number of severe comorbidities (OR 2.2) and higher premorbid CFS (OR 1.3). CONCLUSIONS: There is large variability across European AGUs concerning GOC discussions and treatment limitation decisions. Sharing of information between primary and hospital care about patient preferences is noticeably deficient.
引用
- Piers R, Pautex S, Rexach Cano L, et al. Goals of care discussions and treatment limitation decisions in European acute geriatric units: a one-day cross-sectional study. Age Ageing. 2025. PMID: 39967416. doi:10.1093/ageing/afaf026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。